We conducted cell growth inhibitory experiments using the MuSS cell line with a MIF inhibitor and a SCD1 inhibitor to investigate the role of MIF, SCD1, and the combination of MIF and SCD1 for tumor progression. Here, SCD is linked to neoplasm.